Trial NCT04504045

View at ClinicalTrials.gov 
Org. Study IDs: AKF-395
Secondary IDs: 2020-000162-42

Last trial update was posted on 2022-06-16

MeSH Interventions

Caffeine Efavirenz Losartan Metformin Metoprolol Midazolam

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions


Stopping Reasons

Slow recruitment due to COVID-19, the study was stopped when recruited numbers fulfilled the pre-defined lower sample size.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID